Tech Company Financing Transactions
NSG BioLabs Funding Round
NSG BioLabs closed a $14.5 million funding round on 5/8/2024. Investors included ClavystBio.
Transaction Overview
Company Name
Announced On
5/8/2024
Transaction Type
Venture Equity
Amount
$14,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to augment its infrastructure, services, and benefits for residents, as well as support the expansion of its co-working laboratory and office spaces.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
21 Biopolis Rd, Nucleos North Tower 02-03/05 & 05-01/02
Singapore, 138567
Singapore
Singapore, 138567
Singapore
Phone
Website
Email Address
Overview
NSG BioLabs supports growing life sciences companies with scalable BSL2 wet-lab and office infrastructure. Together with its investment arm NSG Ventures, a global biotech venture capital firm and NSG Tomorrow, a sponsorship and grant programme for early-stage biotech companies, the NSG group helps companies and entrepreneurs take full advantage of Singapore's research strength and rapidly growing academic and startup environment to translate innovative technologies into breakthrough global biotech companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Daphne Teo
Browse more venture capital transactions:
Prev: 5/8/2024: Canopy venture capital transaction
Next: 5/8/2024: Electricity Maps venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs